home / stock / adilw / adilw quote
Last: | $0.0009 |
---|---|
Change Percent: | -66.67% |
Open: | $0.0015 |
Close: | $0.0009 |
High: | $0.0015 |
Low: | $0.0009 |
Volume: | 5,182 |
Last Trade Date Time: | 07/27/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.0009 | $0.0015 | $0.0009 | $0.0015 | $0.0009 | 5,182 | 07-27-2023 |
$0.0021 | $0.002 | $0.0021 | $0.0021 | $0.002 | 23,190 | 07-26-2023 |
$0.0018 | $0.0038 | $0.0018 | $0.0061 | $0.0004 | 43,480 | 07-25-2023 |
$0.0061 | $0.004 | $0.0061 | $0.0061 | $0.0013 | 29,530 | 07-24-2023 |
$0.006 | $0.0057 | $0.006 | $0.006 | $0.0057 | 12,200 | 07-20-2023 |
$0.0057 | $0.0057 | $0.0057 | $0.0057 | $0.0057 | 39,329 | 07-19-2023 |
$0.0057 | $0.006 | $0.0057 | $0.006 | $0.0057 | 13,200 | 07-18-2023 |
$0.006 | $0.006 | $0.006 | $0.006 | $0.006 | 25,421 | 07-17-2023 |
$0.0057 | $0.0084 | $0.0057 | $0.0084 | $0.0057 | 1,100 | 07-13-2023 |
$0.0148 | $0.01 | $0.0148 | $0.0148 | $0.007 | 11,234 | 07-12-2023 |
$0.0081 | $0.0085 | $0.0081 | $0.0085 | $0.008 | 11,141 | 07-11-2023 |
$0.0057 | $0.0057 | $0.0057 | $0.0057 | $0.0057 | 22,140 | 07-06-2023 |
$0.0057 | $0.0057 | $0.0057 | $0.0058 | $0.0057 | 8,212 | 07-05-2023 |
$0.0057 | $0.0057 | $0.0057 | $0.0057 | $0.0057 | 2,205 | 06-30-2023 |
$0.0058 | $0.0058 | $0.0058 | $0.0058 | $0.0058 | 985 | 06-29-2023 |
$0.0088 | $0.0057 | $0.0088 | $0.0088 | $0.0057 | 4,994 | 06-28-2023 |
$0.0058 | $0.0058 | $0.0058 | $0.01 | $0.0057 | 18,407 | 06-27-2023 |
$0.006 | $0.006 | $0.006 | $0.006 | $0.006 | 1,002 | 06-26-2023 |
$0.0059 | $0.0058 | $0.0059 | $0.0199 | $0.0058 | 4,000 | 06-23-2023 |
$0.0057 | $0.0057 | $0.0057 | $0.0057 | $0.0057 | 100 | 06-19-2023 |
News, Short Squeeze, Breakout and More Instantly...
Adial Pharmaceuticals Inc Warrant Company Name:
ADILW Stock Symbol:
NASDAQ Market:
GLEN ALLEN, Va., April 22, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ:ADIL) ("Adial" or the "Company"), a clinical-stage bioph...
GLEN ALLEN, Va., April 22, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders...
GLEN ALLEN, Va., April 10, 2024 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders...